Boris Gabriel

发表

The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer

D. Giesecke, U. Hurst, L. Anastasiadou, 2024, Breast cancer research and treatment.